Trials / Completed
CompletedNCT01056705
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)
The Phase Ⅱ Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 60 Days – 90 Days
- Healthy volunteers
- Accepted
Summary
Based on pre-clinical trial and phase 1 clinical data and principle of GCP, the objective of phase Ⅱ clinical trial is to evaluate safety and immunogenicity of Inactivated Poliomyelitis Vaccine made from Sabin Strains(Sabin IPV).
Detailed description
The Sabin IPV was manufactured with poliovirus type1, 2, 3 Sabin strains and Vero cells by microcarrier culture in 550 liter bioreactors. The virus suspension was harvested ,ultra-concentrated, purified and inactivated with formalin. Three formulations A,B,C of Sabin IPV were used, the DAg contents for A were type1 45,type2 64,type3 67.5 DU /0.5ml/per dose; for B 30,32,45 DU/0.5ml/per dose; for C 15,16,22.5 DU/0.5ml/per dose. Oral Poliomyelitis Vaccine(OPV)was manufactured by Institute of Medical Biology, Chinese Academy of Medical Sciences.Trivalent OPV contains Polioviruses Type 1 6.0 log CCID Type 2 5.0 log Type 3 5.5log /0.1ml/per dose Inactivated Poliomyelitis Vaccine (Salk strains)was manufactured by Sanofi Pasteur DAg contents /0.5ml/per dose were Type 1 40 DU,Type 2 8DU,Type 3 32DU. This is a randomized, blind phase 2 clinical trial. Total 500 infants (ages 60 days to 90 days) were selected , randomized to five groups(each group n=100) Sabin IPV formulations A,B,C,OPV ,Salk IPV were separately given to each group with three doses one month apart respectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Inactivated Poliomyelitis Vaccine (Sabin strains) | Inactivated Poliomyelitis Vaccine (Sabin strains) formulation A. 3x0.5ml intramuscular injections,one month apart. |
| BIOLOGICAL | Inactivated Poliomyelitis Vaccine (Sabin strains) | Inactivated Poliomyelitis Vaccine (Sabin strains) formulation B. 3x0.5ml intramuscular injections, one month apart. |
| BIOLOGICAL | Inactivated Poliomyelitis Vaccine (Sabin strains) | Inactivated Poliomyelitis Vaccine (Sabin strains) formulation C. 3x0.5ml intramuscular injections, one month apart. |
| BIOLOGICAL | Oral Poliomyelitis Vaccine | Oral Poliomyelitis Vaccine (OPV).3x0.5mloral, one month apart. |
| BIOLOGICAL | Inactivated Poliomyelitis Vaccine (Salk strains). | 3x0.5ml intramuscular injections, one month apart. |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-05-01
- Completion
- 2010-08-01
- First posted
- 2010-01-26
- Last updated
- 2016-08-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01056705. Inclusion in this directory is not an endorsement.